Lung Neoplasms: all 7,334 studies

Page 11 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.

• Lorlatinib as the First-line Treatment in China Advanced ALK+ NSCLCRecruitingNCT06092086Phase 2
• Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung CancerRecruitingNCT06086574
• Test-retest Evaluation of [18F]F-AraG PETRecruitingNCT06084806Phase 2
• Rural Illinois Lung Cancer Screening InitiativeRecruitingNCT06084078
• The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer PatientsRecruitingNCT06082492Not applicable
• Prospective Study on Resistance-associated Mutations in Metastatic Lung CancerRecruitingNCT06081270
• SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR MutationsRecruitingNCT06080776Phase 3
• Personalized Accelerated ChEmoRadiation (PACER) for Lung CancerRecruitingNCT06080061Not applicable
• Confocal Laser Endomicroscopy VERificationRecruitingNCT06079970Not applicable
• Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian CohorRecruitingNCT06076005
• Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer TypesRecruitingNCT06075524
• LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer CachexiaRecruitingNCT06073431
• Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer PatientsRecruitingNCT06071013Phase 1/2
• Health Education Approach to Lung ScreeningRecruitingNCT06070870Not applicable
• Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone MetastasesRecruitingNCT06069570Phase 1
• Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung CancerRecruitingNCT06065813Phase 2
• Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom ManagementNot yet recruitingNCT06060964Early Phase 1
• Safety and Efficacy of OBX-115 in Advanced Solid TumorsRecruitingNCT06060613Phase 1/2
• The Alterations of Metabolic Adipo-myokines and Body Composition in End Stage Lung CancerRecruitingNCT06060262
• Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)RecruitingNCT06054854
• A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)RecruitingNCT06053099Not applicable
• Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung CancerRecruitingNCT06052098Not applicable
• A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionRecruitingNCT06051695Phase 1/2
• A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal AntibodyNot yet recruitingNCT06048315Phase 3
• Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer TreatmentRecruitingNCT06047301Not applicable
• A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung CancerRecruitingNCT06046495Phase 1
• T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung CancerNot yet recruitingNCT06045767Phase 2
• Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung CanceRecruitingNCT06043973Phase 3
• Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive MutationsRecruitingNCT06041776Phase 3
• Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsRecruitingNCT06040541Phase 1
• Lung cAncer Robotic Comparative StudyRecruitingNCT06038227
• A Study of Mental Health Care in People With CancerRecruitingNCT06037954Not applicable
• Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and ChemotherapyRecruitingNCT06037733Not applicable
• Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA SequencingRecruitingNCT06036563
• Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly PatientsRecruitingNCT06032052Phase 2
• Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)RecruitingNCT06031688Phase 2
• Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction ImmunochemotherapyNot yet recruitingNCT06031597Phase 3
• IN10018 Combination Therapy in Treatment-naïve ES-SCLCRecruitingNCT06030258Phase 1/2
• Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC PatientsNot yet recruitingNCT06028633Phase 2
• Non-small Cell Lung Cancer With Central Nervous System MetastasisRecruitingNCT06026735
• Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE TrialRecruitingNCT06026111Not applicable
• Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 TherapiesNot yet recruitingNCT06024538
• Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLCNot yet recruitingNCT06024226
• Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and ChemotherapyRecruitingNCT06020430Not applicable
• Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.RecruitingNCT06016569Not applicable
• Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive MutationNot yet recruitingNCT06015568Phase 1
• Validation of Rapid On-site Diagnostics in Early Stage Lung Cancer Sampling With a Higher Harmonic Generation MicroscopeRecruitingNCT06007261
• The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung CancerRecruitingNCT06000358Not applicable
• Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)Not yet recruitingNCT05998993Not applicable
• Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC)RecruitingNCT05996263
• Immunobiology Blood and Tissue Collection of Upper Aerodigestive MalignanciesRecruitingNCT05995821
• Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung CancerNot yet recruitingNCT05994339Phase 2/3
• Role of Bronchoscope in Diagnosis of Lung CancerNot yet recruitingNCT05992740Not applicable
• Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung CancerRecruitingNCT05991895
• Real-World Study on the Efficacy of IBI-322 in Combination With Lenvatinib for the Treatment of Extensive Stage Small Cell Lung CancerRecruitingNCT05991180
• Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung CancerRecruitingNCT05990946Not applicable
• Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangementsRecruitingNCT05987644Phase 1/2
• Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung DiseaseRecruitingNCT05986318Phase 2
• Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung CancerRecruitingNCT05979818Phase 1
• Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung CancerNot yet recruitingNCT05978401Phase 1/2
• Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible ParticipantsRecruitingNCT05978128Not applicable
• Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary OriginRecruitingNCT05977803Not applicable
• Study of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung CancerRecruitingNCT05975944Phase 1/2
• MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung CancerRecruitingNCT05974475
• Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom MonitoringRecruitingNCT05974150
• Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulESRecruitingNCT05968898Not applicable
• Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerRecruitingNCT05965557
• Tirellizumab Combined With Chemotherapy Monotherapy for Non-small Cell Lung CancerNot yet recruitingNCT05965102Phase 1
• Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung CancerRecruitingNCT05965024
• Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR MutationNot yet recruitingNCT05962021Phase 2
• Effect of Exercise Therapy on Psychological State and Clinical Prognosis of Advanced Non-small Cell Lung CancerNot yet recruitingNCT05959265Not applicable
• Multimodal Prehabilitation for Lung Cancer SurgeryRecruitingNCT05955248Not applicable
• A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid TumorsRecruitingNCT05948865Phase 1
• HTL0039732 in Participants With Advanced Solid TumoursRecruitingNCT05944237Phase 1/2
• A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and ChemotherapyRecruitingNCT05942508Phase 1
• A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsRecruitingNCT05941507Phase 1/2
• Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung CancerNot yet recruitingNCT05932264Phase 2
• Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung CancerRecruitingNCT05925751
• Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung CancerRecruitingNCT05925738
• Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.RecruitingNCT05922345Phase 3
• Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung TumorsRecruitingNCT05921474
• A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)RecruitingNCT05920356Phase 3
• A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung CancerRecruitingNCT05913089Phase 2
• Predicting Lung Cancer-Associated Cachexia With PET ImagingRecruitingNCT05912465Not applicable
• Low-dose Radiotherapy Combined With Conventional Fractionated Radiotherapy in Lung Cancer After Immunotherapy ResistanceRecruitingNCT05906329Not applicable
• The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLCNot yet recruitingNCT05904015Phase 2
• A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)RecruitingNCT05903430
• Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung CancerNot yet recruitingNCT05900921Phase 2
• Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical StudyNot yet recruitingNCT05900219Phase 2
• Lung Cancer Screening in High-risk Black IndividualsRecruitingNCT05898594Not applicable
• A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLCRecruitingNCT05896059Phase 2
• Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 TrialNot yet recruitingNCT05891080Phase 2
• Rapid Autopsy Protocol for Patients With Small Cell Lung CancerRecruitingNCT05889546
• LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung CancerRecruitingNCT05886439Phase 1/2
• Acceptance and Commitment Therapy on Fatigue Interference in Patients With Advanced Lung Cancer and Caregiver Burden (ACT)Not yet recruitingNCT05885984Not applicable
• Application of SERS Technology in Clinical Diagnosis and Prognosis of Lung Cancer ImmunotherapyNot yet recruitingNCT05885815
• MYLUNG Consortium Part 3: Observational StudyRecruitingNCT05885698
• Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung CancerNot yet recruitingNCT05882630Phase 1/2
• Application of SERS Technology Based Intraoperative Navigation System in Lung CancerNot yet recruitingNCT05881057
• Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With CancerRecruitingNCT05875870Not applicable

← Lung Neoplasms overview